BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 26, 2026
Home » Authors » Randy Osborne

Randy Osborne

Articles

ARTICLES

NPS's Phase III Bone Treatment Tested In Shuttle's Microgravity

Jan. 21, 2003
By Randy Osborne

Panel Favors Genzyme Over TKT In Fabry Race Fraught With Irony

Jan. 20, 2003
By Randy Osborne
Look up the origins of the word "enzyme" in the dictionary and you'll find it has a possible Greek root, related to the word "juice." Look up "juice," and you'll find that it can be defined as "strength, vigor, vitality" - words seldom associated with the biotechnology sector these days. (BioWorld Financial Watch)
Read More

FDA Stops Gene Therapy Trials; Second French Patient Leukemic

Jan. 16, 2003
By Randy Osborne

BioFocus Enters Amgen Deal, Offers Warning On Financials

Jan. 15, 2003
By Randy Osborne

Durect, Pain Therapeutics Sign Deal For Longer-Acting Opioids

Jan. 15, 2003
By Randy Osborne

Aventis Picks Five Eos Targets; Vaccine Deal Ends With 'Bang'

Jan. 14, 2003
By Randy Osborne

BioFocus Enters Amgen Deal, Offers Warning On Financials

Jan. 14, 2003
By Randy Osborne

SBI, GeneFormatics Merger Mix Of Technologies, Drugs - And Cash

Jan. 13, 2003
By Randy Osborne
In these hard economic times, when you hear anybody in biotechnology say it's "not all about cash," you might suspect the speaker of being na ve or disingenuous. And when such words come out of the straitened genomics sector, they sound even much more suspicious. (BioWorld Financial Watch)
Read More

Chiron, GSK Enter Agreement For Obesity Pathway Research

Jan. 9, 2003
By Randy Osborne
Several months after the company cut three late-stage programs, Chiron Corp. has set about the business of building its pipeline, nailing down a small-molecule partnership with GlaxoSmithKline plc to fuel research in the melanocortin 4 receptor pathway. (BioWorld Today)
Read More

Cephalon, MDS Sign Agreement On Proteomics-Based Research

Jan. 8, 2003
By Randy Osborne
View All Articles by Randy Osborne

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 24, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • Chengdu Mfs Pharma synthesizes new compounds for pain

    BioWorld Science
    Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing